Wolverine Trading’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $18M | Sell |
66,300
-1,500
| -2% | -$408K | 0.01% | 636 |
|
|
2025
Q2 | $18.6M | Buy |
+67,800
| New | +$18.4M | 0.02% | 497 |
|
|
2025
Q1 | – | Sell |
-39,500
| Closed | -$9.15M | – | 4860 |
|
|
2024
Q4 | $9.15M | Sell |
39,500
-12,800
| -24% | -$2.94M | 0.01% | 836 |
|
|
2024
Q3 | $11.4M | Buy |
52,300
+25,800
| +97% | +$5.34M | 0.01% | 632 |
|
|
2024
Q2 | $5.21M | Sell |
26,500
-6,100
| -19% | -$1.26M | 0.01% | 970 |
|
|
2024
Q1 | $7.02M | Buy |
32,600
+9,100
| +39% | +$1.91M | 0.01% | 816 |
|
|
2023
Q4 | $4.95M | Sell |
23,500
-6,300
| -21% | -$1.34M | 0.01% | 1102 |
|
|
2023
Q3 | $5.97M | Sell |
29,800
-9,600
| -24% | -$1.91M | 0.01% | 892 |
|
|
2023
Q2 | $7.22M | Buy |
39,400
+1,600
| +4% | +$296K | 0.01% | 723 |
|
|
2023
Q1 | $7.14M | Buy |
37,800
+8,100
| +27% | +$1.46M | 0.01% | 668 |
|
|
2022
Q4 | $4.99M | Sell |
29,700
-1,100
| -4% | -$191K | 0.01% | 906 |
|
|
2022
Q3 | $5.5M | Sell |
30,800
-900
| -3% | -$178K | 0.01% | 801 |
|
|
2022
Q2 | $6.54M | Sell |
31,700
-2,500
| -7% | -$530K | 0.01% | 700 |
|
|
2022
Q1 | $8.27M | Sell |
34,200
-4,600
| -12% | -$1.08M | 0.01% | 778 |
|
|
2021
Q4 | $8.87M | Sell |
38,800
-18,900
| -33% | -$4.16M | 0.01% | 794 |
|
|
2021
Q3 | $11.3M | Sell |
57,700
-20,200
| -26% | -$4.09M | 0.01% | 745 |
|
|
2021
Q2 | $16.6M | Sell |
77,900
-1,300
| -2% | -$274K | 0.03% | 493 |
|
|
2021
Q1 | $16.2M | Buy |
79,200
+11,400
| +17% | +$2.25M | 0.02% | 479 |
|
|
2020
Q4 | $12.1M | Sell |
67,800
-2,200
| -3% | -$374K | 0.02% | 598 |
|
|
2020
Q3 | $11.6M | Buy |
70,000
+600
| +0.9% | +$101K | 0.03% | 474 |
|
|
2020
Q2 | $11.2M | Sell |
69,400
-4,000
| -5% | -$717K | 0.03% | 425 |
|
|
2020
Q1 | $12.8M | Sell |
73,400
-11,400
| -13% | -$2.27M | 0.04% | 352 |
|
|
2019
Q4 | $16.9M | Sell |
84,800
-9,700
| -10% | -$1.99M | 0.04% | 436 |
|
|
2019
Q3 | $20.2M | Buy |
94,500
+9,800
| +12% | +$2.05M | 0.06% | 279 |
|
|
2019
Q2 | $16.4M | Sell |
84,700
-12,300
| -13% | -$2.27M | 0.05% | 351 |
|
|
2019
Q1 | $16M | Buy |
+97,000
| New | +$17.1M | 0.05% | 325 |
|
|
2018
Q4 | – | Sell |
-115,600
| Closed | -$19.7M | – | 4525 |
|
|
2018
Q3 | $19.7M | Sell |
115,600
-19,200
| -14% | -$3.23M | 0.04% | 305 |
|
|
2018
Q2 | $21.8M | Hold |
134,800
| – | – | 0.05% | 229 |
|
|
2018
Q1 | $21.8M | Buy |
134,800
+65,900
| +96% | +$10.5M | 0.05% | 229 |
|
|
2017
Q4 | $10.1M | Sell |
68,900
-95,400
| -58% | -$13.6M | 0.04% | 506 |
|
|
2017
Q3 | $22.3M | Buy |
+164,300
| New | +$20.8M | 0.09% | 193 |
|
|
2017
Q2 | – | Sell |
-73,300
| Closed | -$8.71M | – | 4327 |
|
|
2017
Q1 | $8.71M | Sell |
73,300
-500
| -0.7% | -$60.1K | 0.05% | 397 |
|
|
2016
Q4 | $8.51M | Sell |
73,800
-7,200
| -9% | -$801K | 0.04% | 445 |
|
|
2016
Q3 | $8.48M | Sell |
81,000
-66,800
| -45% | -$6.97M | 0.04% | 499 |
|
|
2016
Q2 | $14.2M | Buy |
+147,800
| New | +$14M | 0.08% | 242 |
|
Other funds holding CME
Wolverine Trading's CME Position: Q3 2025 in Review
Wolverine Trading increased its CME Group (CME) stake by 113% in Q3 2025, buying an estimated $634K and bringing the position to 4,397 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2717.
Wolverine Trading first reported a position in CME in Q3 2016 and has held it in 27 quarters since. The position peaked at $26.1M in Q4 2019. 1,650 funds tracked by Wall St. Rank hold CME as of Q3 2025.
- Wolverine Trading held 4,397 shares of CME Group worth $1.2M as of Q3 2025.
- Wolverine Trading bought 2,331 CME Group shares in Q3 2025, an estimated $634K.
- CME Group made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2717 holding.
- Wolverine Trading first reported a position in CME Group in Q3 2016 and has held it in 27 quarters since.
- Wolverine Trading's CME Group position peaked at $26.1M in Q4 2019.
- 1,650 funds tracked by Wall St. Rank held CME Group as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.